Picture of Polarean Imaging logo

POLX Polarean Imaging Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+5.91%
3m-10.45%
6m+2.31%
1yr-5.97%
Volume Change (%)
10d/3m-48.35%
Price vs... (%)
52w High-23.91%
50d MA+5.66%
200d MA+1.94%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-59.59%
Return on Equity-49.39%
Operating Margin-1127.28%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Polarean Imaging EPS forecast chart

Profile Summary

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary function imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Company’s technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Company’s subsidiary is Polarean, Inc.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
October 24th, 2016
Public Since
March 29th, 2018
No. of Employees
28
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
213,047,509

POLX Share Price Performance

Similar to POLX

Picture of Abingdon Health logo

Abingdon Health

gb flag iconLondon Stock Exchange

Picture of Advanced Medical Solutions logo

Advanced Medical Solutions

gb flag iconLondon Stock Exchange

Picture of Advanced Oncotherapy logo

Advanced Oncotherapy

gb flag iconLondon Stock Exchange

Picture of Angle logo

Angle

gb flag iconLondon Stock Exchange

Picture of Aptamer logo

Aptamer

gb flag iconLondon Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email